Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19.
作者信息
Sean Ong Xuan Rui, Condon Benjamin, Bagguley Dominic, Lawrentschuk Nathan, Azad Arun, Murphy Declan
机构信息
Division of Cancer Surgery, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.
EJ Whitten Foundation Prostate Cancer Research Centre, Epworth Health, Victoria, Australia.
出版信息
Future Oncol. 2020 Jul;16(20):1409-1411. doi: 10.2217/fon-2020-0388. Epub 2020 May 14.
Abstract
摘要
相似文献
1
Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19.
Future Oncol. 2020 Jul;16(20):1409-1411. doi: 10.2217/fon-2020-0388. Epub 2020 May 14.
2
Oncology clinical trials in the time of COVID-19: how a pandemic can revolutionize patients' care.
Future Oncol. 2020 Jul;16(20):1413-1415. doi: 10.2217/fon-2020-0364. Epub 2020 May 14.
3
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).
Ann Oncol. 2020 Aug;31(8):1040-1045. doi: 10.1016/j.annonc.2020.04.479. Epub 2020 May 6.
4
Sequencing Treatments for Cancer During the COVID-19 Pandemic.
Am J Clin Oncol. 2020 Jul;43(7):457-458. doi: 10.1097/COC.0000000000000717.
5
Emergency Open-source Three-dimensional Printable Ventilator Circuit Splitter and Flow Regulator during the COVID-19 Pandemic.
Anesthesiology. 2020 Jul;133(1):246-248. doi: 10.1097/ALN.0000000000003332.
6
Staying Ahead of the Wave.
N Engl J Med. 2020 Apr 30;382(18):e44. doi: 10.1056/NEJMc2009409. Epub 2020 Apr 13.
7
COVID-19 and The Prostate Cancer Connection.
Can J Urol. 2020 Oct;27(5):10346.
8
Does androgen deprivation therapy in patients with prostate cancer protect from COVID-19?
Rev Assoc Med Bras (1992). 2020 Oct;66(10):1314-1315. doi: 10.1590/1806-9282.66.10.1314.
9
Androgen deprivation and SARS-CoV-2 in men with prostate cancer.
Ann Oncol. 2020 Oct;31(10):1417-1418. doi: 10.1016/j.annonc.2020.06.015. Epub 2020 Jun 29.
10
On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2.
Ann Oncol. 2020 Oct;31(10):1415-1416. doi: 10.1016/j.annonc.2020.06.005. Epub 2020 Jun 18.
引用本文的文献
1
A cohort analysis of patients receiving neoadjuvant androgen deprivation therapy prior to robot-assisted laparoscopic prostatectomy during the Covid-19 pandemic.
J Clin Urol. 2023 Mar;16(2):131-139. doi: 10.1177/20514158211022216. Epub 2021 Jun 7.
2
Determinants of COVID-19 Outcome as Predictors of Delayed Healthcare Services among Adults ≥50 Years during the Pandemic: 2006-2020 Health and Retirement Study.
Int J Environ Res Public Health. 2022 Sep 23;19(19):12059. doi: 10.3390/ijerph191912059.
3
Implications of COVID-19 on urological laparoscopic surgery.
Future Oncol. 2020 Sep;16(26):1941-1945. doi: 10.2217/fon-2020-0533. Epub 2020 Jun 27.
本文引用的文献
1
Incidence of the adverse effects of androgen deprivation therapy for prostate cancer: a systematic literature review.
Support Care Cancer. 2020 May;28(5):2079-2093. doi: 10.1007/s00520-019-05255-5. Epub 2020 Jan 7.
2
Prostate cancer outcomes and delays in care.
Int Urol Nephrol. 2017 Mar;49(3):449-455. doi: 10.1007/s11255-017-1508-z. Epub 2017 Jan 12.
3
Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: Can surgery be postponed safely?
Urol Oncol. 2017 Apr;35(4):150.e9-150.e15. doi: 10.1016/j.urolonc.2016.11.010. Epub 2016 Dec 13.
4
A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment.
Eur Urol. 2016 Dec;70(6):954-960. doi: 10.1016/j.eururo.2016.06.007. Epub 2016 Jun 19.
5
Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.
J Clin Oncol. 2015 Oct 20;33(30):3379-85. doi: 10.1200/JCO.2015.62.5764. Epub 2015 Aug 31.
6
Long-term follow-up of a large active surveillance cohort of patients with prostate cancer.
J Clin Oncol. 2015 Jan 20;33(3):272-7. doi: 10.1200/JCO.2014.55.1192. Epub 2014 Dec 15.
7
Effect of delaying surgery on radical prostatectomy outcomes: a contemporary analysis.
BJU Int. 2012 Jul;110(2):211-6. doi: 10.1111/j.1464-410X.2011.10666.x. Epub 2011 Nov 16.
8
Delay of surgery in men with low risk prostate cancer.
J Urol. 2011 Jun;185(6):2143-7. doi: 10.1016/j.juro.2011.02.009. Epub 2011 Apr 15.
9
Outcome of primary versus deferred radical prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study.
J Urol. 2010 Oct;184(4):1322-7. doi: 10.1016/j.juro.2010.06.008. Epub 2010 Aug 17.
10
The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
Contemp Clin Trials. 2009 Jan;30(1):81-7. doi: 10.1016/j.cct.2008.08.002. Epub 2008 Aug 23.
Zotero 插件